Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion
1996

Nm23 Expression in Endometrial and Cervical Cancer

Sample size: 98 publication Evidence: moderate

Author Information

Author(s): M Marone, G Scambia, G Ferrandina, C Giannitelli, P Benedetti-Panici, S Iacovella, A Leone, S Mancuso

Primary Institution: Catholic University, Rome; Istituto Oncologico di Bari, Italy

Hypothesis

The study investigates the correlation between nm23 expression and lymph node involvement and myometrial invasion in endometrial and cervical cancer.

Conclusion

Nm23 levels may serve as a new marker for prognostic characterization and treatment planning in uterine tumor patients.

Supporting Evidence

  • Cervical cancer patients with lymph node involvement had significantly lower nm23 levels.
  • Nm23 levels were inversely correlated with myometrial invasion in endometrial cancer.
  • Median nm23-H2 levels were higher than nm23-H1 levels in both tissues.

Takeaway

This study looks at a protein called nm23 in cancer samples to see if it can help doctors understand how aggressive the cancer is.

Methodology

The study analyzed nm23-H1 and nm23-H2 expression in normal and cancerous tissues using Northern and Western blotting.

Limitations

The study did not find significant correlations with stage or grade of differentiation.

Participant Demographics

Included 13 normal endometrial samples, 45 endometrial cancer samples, and 40 cervical cancer samples.

Statistical Information

P-Value

p<0.007 for H1 and p<0.009 for H2 in cervical cancer; p<0.003 for myometrial invasion.

Statistical Significance

p<0.003

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication